Bioventus (BVS) Net Cash Flow (2020 - 2026)
Bioventus' (BVS) quarterly Net Cash Flow came in at -$14.8 million in Q1 2026, up 23.04% YoY from -$12.0 million in Q1 2025, and down 265.35% on a QoQ basis from $8.9 million in Q4 2025.
Bioventus (BVS) Net Cash Flow (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Net Cash Flow data on file, last reported at -$14.8 million in Q1 2026.
- Quarterly Net Cash Flow rose 23.04% year-over-year to -$14.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 1846.62% YoY) and the FY2025 annual result came in at $9.3 million, up 29.35% from the prior year.
- Net Cash Flow declined to -$14.8 million in Q1 2026, from $8.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $17.0 million in Q2 2023 to a low of -$41.4 million in Q3 2022.
- A 5-year average of -$3.0 million and a median of -$4.3 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 583.78% — and 2025, when it jumped 1465.85%.
- Tracing BVS's Net Cash Flow over 5 years: stood at -$4.5 million in 2022, then jumped by 319.23% to $9.8 million in 2023, then tumbled by 94.15% to $571000.0 in 2024, then jumped by 1465.85% to $8.9 million in 2025, then slumped by 265.35% to -$14.8 million in 2026.
- The last three Net Cash Flow figures came in at -$14.8 million (Q1 2026), $8.9 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -6.02 Mn |
| Jun 27, 2026 | -6.02 Mn |
| Mar 28, 2026 | -14.78 Mn |
| Mar 28, 2026 | -14.78 Mn |
| Dec 31, 2025 | 8.94 Mn |
| Dec 31, 2025 | 8.94 Mn |
| Sep 27, 2025 | 9.65 Mn |
| Sep 27, 2025 | 9.65 Mn |
| Jun 28, 2025 | 9.91 Mn |
| Jun 28, 2025 | 9.91 Mn |
| Mar 29, 2025 | -19.21 Mn |
| Mar 29, 2025 | -19.21 Mn |
| Dec 31, 2024 | 571,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 28, 2024 | 10.61 Mn |
| Sep 28, 2024 | 10.61 Mn |
| Jun 29, 2024 | 7.24 Mn |
| Jun 29, 2024 | 7.24 Mn |
| Mar 30, 2024 | -11.25 Mn |
| Mar 30, 2024 | -11.25 Mn |